
In an insured population with advanced lung cancer, clinical trial participants had lower or similar total health care costs compared with nonparticipants.
The American Journal of Managed Care
about 27 years ago
Is a Third-Trimester Antibody Screen in Rh+ Women Necessary?about 27 years ago
Drug Therapy of Allergic Rhinitisabout 27 years ago
Rethinking Formulary Strategy: Management and Measurement Considerations